Viking Therapeutics, Inc. (VKTX) vs Xenon Pharmaceuticals Inc. (XENE)
A side-by-side comparison of Viking Therapeutics, Inc. and Xenon Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
VKTX
Viking Therapeutics, Inc.
$28.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XENE
Xenon Pharmaceuticals Inc.
$36.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — VKTX vs XENE
growth of $100 · dividends reinvested · last 10yVKTX +2021.7% (+35.7%/yr)XENE +355.4% (+16.4%/yr)VKTX compounded faster over this window
VKTX XENE
VKTX vs XENE: by the numbers
- •XENE is the larger company ($3.54B vs $3.31B market cap).
- •Both run net losses; VKTX's is the smaller (0.00% vs -4612.13% net margin).
Metrics side by side
Valuation
| Metric | VKTX | XENE |
|---|---|---|
| P/B ratio | 8.11 | 2.85 |
Profitability
| Metric | VKTX | XENE |
|---|---|---|
| Gross margin | 0.00% | 66.09% |
| Operating margin | 0.00% | -4974.27% |
| Net margin | 0.00% | -4612.13% |
| ROE | -130.98% | -32.94% |
| ROIC | -135.85% | -35.27% |
Growth (annualized)
| Metric | VKTX | XENE |
|---|---|---|
| Total return CAGR (5Y) | 37.36% | 4.61% |
Frequently asked
- How have VKTX and XENE total returns compared?
- Over the past 10 years, VKTX delivered 35.25% and XENE delivered 17.07% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Viking Therapeutics ROEXenon Pharmaceuticals ROEViking Therapeutics operating marginXenon Pharmaceuticals operating marginViking Therapeutics revenue growthXenon Pharmaceuticals revenue growthViking Therapeutics free cash flowXenon Pharmaceuticals free cash flow
Viking Therapeutics & Xenon Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.